Litigation Details for Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.. (D. Del. 2015)
✉ Email this page to a colleague
Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.. (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-06-03 |
| Court | District Court, D. Delaware | Date Terminated | 2020-10-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | ACTAVIS LABORATORIES FL, INC.; ANDRX CORPORATION | ||
| Patents | 7,375,111; 7,462,626; 8,088,786; 8,318,788; 8,722,085; 8,815,889; 8,916,195; 9,125,868 | ||
| Attorneys | Dan Constantinescu; Willam F Cavanaugh , Jr. | ||
| Firms | Morris, Nichols, Arsht & Tunnell; Polsinelli PC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc..
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc.. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-06-03 | 1 | THE PATENTS-IN-SUIT 28. Orexigen owns United States Patent No. 7,375,111 (“the ’111…action for infringement of United States Patent Nos. 7,375,111; 7,462,626; 8,088,786; 8,318,788; 8,722,085… This is a civil action for patent infringement arising under the patent laws of the United States, …8,916,195 (collectively, “the patents- in-suit”). This action arises under the Patent Laws of the United States…111 patent”) titled “Compositions for Affecting Weight Loss.” The ’111 patent was duly and legally issued | External link to document | |
| 2017-08-30 | 181 | and Proposed Order of Dismissal of U.S. Patent No. 9,125,868 and Certain Other Claims, by Actavis Laboratories…2015 20 October 2020 1:15-cv-00451 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-08-31 | 182 | 26, and 31 of United States Patent No. 7,462,626 ("the '626 Patent") (collectively, …claims of the '195 Patent, the ' 111 Patent, and the '626 Patent other than the …infringement of Claim 11 of U.S. Patent No. 8,916,195 ("the '195 Patent"), Claim 1 of United…United States Patent No. 7,375, 111 ("the '111 Patent"), and Claims 2, 15, 26… (ii) United States Patent No. 9,125,868 ("the '868 Patent") in its entirety ((i | External link to document | |
| 2017-10-13 | 184 | three patents-in-suit: U.S. Patent Nos. 7,462,626 ("the '626 patent"), 7,375,111 ("… '626 patent, claim 1 of the '111 patent, and claim 11 of the '195 patent are invalid.…infringement of four patents. (D.I. 47). Prior to trial, Plaintiff withdrew one of the four patents (see D.I. …quot;the ' 111 patent"), and 8, 916, 19 5 ("the ' 195 patent"). The Court held… combination. (' 111 patent, claim 1). The '195 patent is directed to methods of treating | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
